Pediatric blinatumomab preparation: Risk assessment on SmPC for software compliance.
Mario CirinoRiccardo ProvasiIrina CebulecClara PalmieriPaolo SchincariolDavide ZanonPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Computerizing the preparation of anti-blastic drugs is a necessary path for the safety of the patient and all the operators involved, however it may be necessary to make changes in the preparation process to allow the software to work correctly. The comparison between pharmacist, clinician and, where necessary, the manufacturer of the drug, was effective in the preparation of this drug.